BDTX
Price
$1.61
Change
+$0.03 (+1.90%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
88.42M
13 days until earnings call
SLRN
Price
$2.17
Change
-$0.09 (-4.00%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
235.66M
49 days until earnings call
Ad is loading...

BDTX vs SLRN

Header iconBDTX vs SLRN Comparison
Open Charts BDTX vs SLRNBanner chart's image
Black Diamond Therapeutics
Price$1.61
Change+$0.03 (+1.90%)
Volume$6.74K
Capitalization88.42M
ACELYRIN
Price$2.17
Change-$0.09 (-4.00%)
Volume$30.81K
Capitalization235.66M
BDTX vs SLRN Comparison Chart
Loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BDTX vs. SLRN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDTX is a Buy and SLRN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BDTX: $1.58 vs. SLRN: $2.25)
Brand notoriety: BDTX and SLRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDTX: 19% vs. SLRN: 20%
Market capitalization -- BDTX: $88.42M vs. SLRN: $235.66M
BDTX [@Biotechnology] is valued at $88.42M. SLRN’s [@Biotechnology] market capitalization is $235.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDTX’s FA Score shows that 1 FA rating(s) are green whileSLRN’s FA Score has 1 green FA rating(s).

  • BDTX’s FA Score: 1 green, 4 red.
  • SLRN’s FA Score: 1 green, 4 red.
According to our system of comparison, SLRN is a better buy in the long-term than BDTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDTX’s TA Score shows that 5 TA indicator(s) are bullish while SLRN’s TA Score has 6 bullish TA indicator(s).

  • BDTX’s TA Score: 5 bullish, 3 bearish.
  • SLRN’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both BDTX and SLRN are a good buy in the short-term.

Price Growth

BDTX (@Biotechnology) experienced а +15.81% price change this week, while SLRN (@Biotechnology) price change was +2.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.07%. For the same industry, the average monthly price growth was -6.06%, and the average quarterly price growth was -12.59%.

Reported Earning Dates

BDTX is expected to report earnings on Aug 12, 2025.

SLRN is expected to report earnings on Jun 12, 2025.

Industries' Descriptions

@Biotechnology (+7.07% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLRN($236M) has a higher market cap than BDTX($88.4M). BDTX YTD gains are higher at: -26.402 vs. SLRN (-28.344). BDTX has higher annual earnings (EBITDA): -78.44M vs. SLRN (-324.52M). SLRN has more cash in the bank: 562M vs. BDTX (98.6M). SLRN has less debt than BDTX: SLRN (6.56M) vs BDTX (22.2M). BDTX (0) and SLRN (0) have equivalent revenues.
BDTXSLRNBDTX / SLRN
Capitalization88.4M236M37%
EBITDA-78.44M-324.52M24%
Gain YTD-26.402-28.34493%
P/E RatioN/AN/A-
Revenue00-
Total Cash98.6M562M18%
Total Debt22.2M6.56M339%
TECHNICAL ANALYSIS
Technical Analysis
BDTXSLRN
RSI
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
88%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 17 days ago
90%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Ad is loading...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AGRCX8.89N/A
N/A
AB Growth C
AVEMX26.95N/A
N/A
Ave Maria Value
ADNPX12.39N/A
N/A
American Beacon ARK Transfmt Innov Inv
TSWMX9.28N/A
N/A
TSW Emerging Markets Institutional
ACILX25.35N/A
N/A
American Century Heritage G

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with ACIU. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then ACIU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
+0.96%
ACIU - BDTX
54%
Loosely correlated
+4.67%
RLAY - BDTX
45%
Loosely correlated
+6.14%
CCCC - BDTX
43%
Loosely correlated
+3.21%
PRME - BDTX
42%
Loosely correlated
+4.14%
ATOS - BDTX
41%
Loosely correlated
+11.25%
More

SLRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLRN has been loosely correlated with CMND. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if SLRN jumps, then CMND could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLRN
1D Price
Change %
SLRN100%
-3.85%
CMND - SLRN
38%
Loosely correlated
-2.36%
THAR - SLRN
36%
Loosely correlated
+3.03%
SGMT - SLRN
33%
Loosely correlated
+9.02%
IDYA - SLRN
32%
Poorly correlated
+0.91%
BDTX - SLRN
32%
Poorly correlated
+0.96%
More